Blood filtering treatment for septic shock and blood vessel health
Part of Heart & circulation, Infections clinical trials.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have septic shock with high lactate levels (2-8 mmol/L).
- You still need high doses of blood pressure medication (norepinephrine >0.5 µg/kg/min).
- You are on steroid treatment for at least 30 minutes.
- You have signs of poor blood flow, like high lactate or slow capillary refill time.
- You are between 18 and 80 years old.
- You have a central line and an arterial line in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a new blood-cleansing device (HemoSystem REBOOT) that may help people with sepsis by removing harmful substances and improving immune function. It is for critically ill patients whose immune systems remain suppressed despite standard sepsis treatment.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
This trial tests whether using specific safety signals can prevent harm from too much fluid given during septic shock. It may help guide doctors to stop fluids at the right time.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.